Design, synthesis and antitubercular activity of compounds containing Aryl and heteroaryl groups with alkylaminoethyl chains

Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry

Volumn 48, Issue 8, 2009, Pages 1121-1127

  Panda, Gautam ^a   Parai, Maloy Kumar ^a   Srivastava, Ajay Kumar ^a   Chaturvedi, Vinita ^a   Manju, Y K ^a   Sinha, Sudhir ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Alkylaminoethyl chains; Pyrazinamide; Tuberculosis

Indexed keywords

EID: 70349911360     PISSN: 03764699     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. (a) Dutt A K & Stead W W, in Tuberculosis and Nontuberculosis Mycobacterial Infections, 4lh edn, edited by David S W B Saunders, 1999, p 3;
2. (b) Murray C J L, Styblo K. & Rouillon A, in Disease Control Priorities in Developing Countries, Jamison D T & Mosely W H, Eds, (Oxford University Press: New York), 1993, p 233;
3. (c) Slyblo K, Bull Int Union Tuberc, 65, 1990, 24;
4. (d) Mdluli K & Spigelman M Current Opinion in Pharmacology, 2006, 1, 6;
5. (e) Baumann S, Eddine A N & Kaufmann S, Current Opinion in Immunology, 2006, 18, 438;
6. (f) Sizaire V, Nackers F, Comte E. & Portaels F, The Lancet Infectious Diseases, 6, 2006, 288;
7. (g) Spigelman M & Gillespie S, The Lancet, 367, 2006, 945;
8. (h) Zhang Y, Post-Martens K, & Denkin S, Drug Discovery Today, 11, 2006, 21.
9. (i) Pauli G F, Case R J, Inui T, Wang Y, Cho S, Fischer N S, & Franzblau S G, Life Sciences, 78, 2005, 485;
10. (i) Ballell L, Field R A, Duncan K & Young R J, Antimicrobial Agents Chemotherapy, 2005, 2153.
11. (a) Martien W B, Bull World Health Org, 80, 2002, 501;
12. (b) Snider D E J, Raviglione M & Kochi A, in Tuberculosis: Pathogenesis Protection and Control; Bloom, B R, Eds. (American Society of Microbiology: Washington, DC). 1994, p 2;
13. (c) Rouhi A M, Chem Eng News, 77, 1999, 52;
14. (d) Pilheu J A, Int J Tuberc, Lung Dis, 2, 1998, 696;
15. (e) Raviglione M C, Snider D E & Kochi A, J Am Med Assoc, 273, 1995, 220;
16. (f) Willcox P A, Curr Opin Pulm Med, 2000, 6, 198;
17. (g) Me'ndez A P, Raviglione M C, Laszlo A, Binkin N, Rieder H L, Bustrco F, Cohn D L, Weczenbeek C S B L-van, Kim S J, Chaulet P, & Nunn PN, Engl J Med, 338, 1998, 1641.
18. (a) O'Brien R J, & Nunn P P, Am J Respir Crit Care Med, 163, 2001, 1055;
19. (b) Harries A D & Mahler D, TB/HIV, A Clinical Manual, World Healt Organization: Geneve, 1996;
20. (c) Hamilton C D Curr Infect Dis Rep, 1, 1999, 80;
21. (d) Migliori G B Ambrosetti M, Fattorini L, Penati V, Vaccarino P, Besozzi G, Ortona L, Saltini C, Ore ci G, Moro M L, Lona E & Cassone A, Int J Tuberc Lung Dis, 4, 2000, 940;
22. (e) Andries K, Verhasselt P, Guillemont J, Gohlmann H W H, Neefs J M, Winkler H, Gestel J V, Timmerman P, Zhu M, Lee E, Williams P, Chaffoy D, Huitric E, Hoffner S, Cambau E, Pernot C T, Lounis N & Jarlier V, Science, 307, 2005, 223.
23. (a) Burman W J & Jones B E, Am J Respir Crit Care Med, 164, 2001, 7;
24. (b) Guillermont J, Patent (International Publication Number: WO 2004/011436. International Publication Date: 5 February 2004;
25. (c) Vangapandu S, Jain M, Jain R, Kaur S & Singh P P, Bioorg Med Chem, 12, 2004. 2501.
26. (a) Parai M K, Panda G, Chaturvedi V, Manju Y K & Sinha S, Med Chem Letts, 18, 2008, 289;
27. (b) Das S K, Panda G, Chaturvedi V, Manju Y S, Gaikwad A K & Sinha S, Med Chem Letts, 17, 2007, 5586;
28. (c) Panda G, Parai M K, Das S K, Shagufta Sinha M, Chaturvedi V, Srivastava A K Manju Y S, Gaikwad A K & Sinha S, Eur J Med Chem, 42, 2007, 410;
29. (d) Shagufta, Kumar A, Panda G & Siddiqi I. J Mol Model 13, 2007, 99;
30. (e) Panda G, Mishra J K, Sinha S, Gaikwad A K, Srivastava A K, Srivastava R & Srivastava B S, Arkivoc, 2005, ii, 29;
31. (f) Panda G, Shagufta, Srivastava A K, & Sinha S, Bioorg Med Chem Lett, 15, 2005, 5222.
32. (g) Panda G, Shagufta. Mishra J K, Chaturvedi V, Srivastava A K, Srivastava R & Srivastava B S, Bioorg Med Chem. 12, 2004, 5269.
33. Siddiqi S, Clinical Microbiology Handbook, (ASM Press: Washington, D. C), 1992, 1.